These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3100076)
21. [in vivo reappearance of injected cryoprecopitate (factor VIII concentrates) in patients with hemophilia A]. Kuble M; Wegner H; Cron D Z Gesamte Inn Med; 1973 Oct; 28(20):608-14. PubMed ID: 4767194 [No Abstract] [Full Text] [Related]
22. [Cryoprecipitation and dextran precipitation in obtaining factor VIII concentrates: results of redetecting antihemophilic globulin A in a patient]. Kubel M; Wegner H; Liebe S Z Gesamte Inn Med; 1974 Mar; 29(6):236-40. PubMed ID: 4409090 [No Abstract] [Full Text] [Related]
23. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate. Tsoukas C; Gervais F; Fuks A; Guttmann RD; Strawczynski H; Shuster J; Gold P Can Med Assoc J; 1983 Oct; 129(7):713-7. PubMed ID: 6225504 [TBL] [Abstract][Full Text] [Related]
24. The treatment of classical hemophilia with factor 8 concentrates. Waterbury L; Frenkel EP Clin Anesth; 1968; 3():288-97. PubMed ID: 4902367 [No Abstract] [Full Text] [Related]
25. [Cryamine--a new factor VIII preparation]. Tarasova LN; Dumkin IM Gematol Transfuziol; 1989 Aug; 34(8):53-6. PubMed ID: 2511060 [No Abstract] [Full Text] [Related]
26. Proceedings: Improvement of the preparation of factor VIII concentrates. Vermeer C; Soute BA; Brummelhuis HG Thromb Diath Haemorrh; 1975 Nov; 34(2):589-90. PubMed ID: 1198501 [No Abstract] [Full Text] [Related]
27. The development of the technology and capacity for the production of factor VIII for the treatment of hemophilia A. Aronson DL Transfusion; 1990 Oct; 30(8):748-58. PubMed ID: 2120808 [No Abstract] [Full Text] [Related]
28. [Hemophilia and AIDS]. Marbet GA Schweiz Rundsch Med Prax; 1989 Jan; 78(1-2):3-4. PubMed ID: 2492672 [No Abstract] [Full Text] [Related]
29. Use of aliphatic amino acid precipitated antihemophilic factor in therapy of hemophilia. Brinkhous KM; Wagner RH; Roberts HR; Webster WP Bibl Haematol; 1968; 29():1104-8. PubMed ID: 5700305 [No Abstract] [Full Text] [Related]
30. Hepatitis C and pasteurised factor VIII and IX concentrates. Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095 [No Abstract] [Full Text] [Related]
31. [The HIV problem of factor VIII-substituted hemophiliacs from the diagnostic and prognostic viewpoints]. Wernet P; Göhring S; Sugg U; Brackmann HH; Kessler M; Egli H; Schneider W Beitr Infusionther Klin Ernahr; 1987; 18():21-4. PubMed ID: 3125827 [No Abstract] [Full Text] [Related]
32. [Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates]. Ikematsu S; Yorifuji H; Arai M; Fukutake K Rinsho Ketsueki; 1988 May; 29(5):628-34. PubMed ID: 3145993 [No Abstract] [Full Text] [Related]
33. [Viral inactivation of antihemophilic factors in acquired immunodeficiency syndrome (AIDS)]. Liras A Sangre (Barc); 1988 Feb; 33(1):34-8. PubMed ID: 3132744 [No Abstract] [Full Text] [Related]
34. [T-lymphocyte subpopulations in hemophiliacs and other groups at risk for the acquired immunodeficiency syndrome (AIDS)]. Gallart T Med Clin (Barc); 1984 Oct; 83(12):492-6. PubMed ID: 6096646 [No Abstract] [Full Text] [Related]
35. Pathogenesis of AIDS in hemophilia. Ablin RJ Ann Allergy; 1990 Mar; 64(3):322. PubMed ID: 2106808 [No Abstract] [Full Text] [Related]